1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Drug Discovery Technologies, BCC Research

Drug Discovery Technologies, BCC Research

  • February 2015
  • -
  • BCC Research
  • -
  • 253 pages

REPORT HIGHLIGHTS

The global market for drug discovery technologies reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019.

This report provides:

An overview of the global markets for drug discovery technologies.
Analyses of global market trends, with data from 2012-2014, and projections of CAGRs through 2019.
A look at the current state of the drug discovery market, existing platforms and products on the market, and detailed analysis of the competitive environments including new, potential venues for novel technologies and approaches.
Descriptions of various products such as bioanalytical instruments, high-throughput screening devices, informatics, and microarrays.
Analyses of the main positive and negative factors in each sector of the market, potential future trends, and emerging technologies accross different segments of the industry.

SCOPE OF THE STUDY

BCC Research conducted an assessment of the market, which includes the global and regional breakdown of sales data, market forecasting, available drug discovery technologies in the market, application of the technologies in commercial and research practice, regulatory aspects, patent analysis, market leaders and market share and so forth for the drug discovery technologies.

The report offers a summary of the global drug discovery technologies market along with region-wise sales analysis of regions such as North America (the U.S. and Canada), Europe and emerging markets (Asian countries, South America, parts of Africa, Russia etc.). The application of drug discovery technologies is based on the commercial and R&D uses of those technologies/products/platforms.

The sales data for the global and regional markets were substantiated for the present and projected values through statistical analysis. The technology details in the report are based on their present/prospective application and expediency.

Table Of Contents

Drug Discovery Technologies, BCC Research

Chapter- 1: INTRODUCTION - Complimentary 4

STUDY OBJECTIVES
REASONS FOR DOING THIS STUDY
CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ANALYSTS' CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER

Chapter- 2: EXECUTIVE SUMMARY 2

Table Summary : GLOBAL REVENUE OF DRUG DISCOVERY TECHNOLOGIES, BY REGION, THROUGH 2019
Figure Summary : GLOBAL REVENUE OF DRUG DISCOVERY TECHNOLOGIES, BY REGION, 2012-2019

Chapter- 3: OVERVIEW 26

CLASSIFICATION
DRUG DISCOVERY PROCESS

Chapter- 4: REGULATORY ASPECTS 7

DRUG DEVELOPMENT TECHNOLOGIES AND REGULATIONS
REGULATORY DEVELOPMENTS OF DRUG DISCOVERY TECHNOLOGIES
Figure 2 : STEPS TO DRUG DISCOVERY UNTIL REGULATORY APPROVAL

Chapter- 5: NEW DEVELOPMENTS 18

Table 4 : NEW DEVELOPMENTS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2014
Table 5 : AWARDS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2014
Table 6 : NEW DEVELOPMENTS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2013
Table 7 : AWARDS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2013
Table 8 : NEW DEVELOPMENTS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2012
Table 9 : AWARDS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2012

Chapter- 6: MARKET ANALYSIS 63

MARKET BY TYPE
MARKET BY REGION

Chapter- 7: INDUSTRY STRUCTURE 30

HIGH-THROUGHPUT SCREENING
BIOANALYTICAL INSTRUMENTS
CELL-BASED ASSAYS AND REAGENTS
PROTEOMICS
GENOMICS
BIOINFORMATICS
OTHER DRUG DISCOVERY TECHNOLOGIES

Chapter- 8: MARKET BY APPLICATION 22

INDUSTRIAL PHARMACEUTICAL/ BIOPHARMACEUTICAL MANUFACTURING
PHARMACEUTICAL/ BIOPHARMACEUTICAL RESEARCH AND DEVELOPMENT
GLOBAL DRUG DISCOVERY TECHNOLOGY MARKET BY APPLICATION
HIGH-THROUGHPUT SCREENING
BIOANALYTICAL INSTRUMENTS
CELL-BASED ASSAYS AND REAGENTS
PROTEOMICS TECHNOLOGY
GENOMICS TECHNOLOGY
BIOINFORMATICS TECHNOLOGY
OTHER DRUG DISCOVERY TECHNOLOGIES

Chapter- 9: PATENT ANALYSIS 25

PATENTS BY YEAR
PATENTS BY DRUG DISCOVERY TECHNOLOGIES AND PRODUCT TYPE
PATENTS BY COUNTRY
PATENTS BY COMPANY
PATENTS BY ASSIGNEE

Chapter- 10: CURRENT SITUATION 6

NEW DRUG DISCOVERY TECHNOLOGIES AND PLATFORMS
FACTORS AFFECTING THE MARKET FOR DRUG DISCOVERY TECHNOLOGIES
CURRENT DRIVERS FOR THE MARKET OF DRUG DISCOVERY TECHNOLOGIES
COLLABORATIONS/ACQUISITIONS

Chapter- 11: COMPANY PROFILES 46

AB SCIEX
ACCELRYS (NOW BIOVIA)
AFFYMETRIX INC.
AGILENT TECHNOLOGIES INC
AMETEK PROCESS INSTRUMENTS
APPLIED MATHS NV
BAYER TECHNOLOGY SERVICES GMBH
BD BIOSCIENCES
BECKMAN COULTER INC.
BIOCRATES LIFE SCIENCES AG
BIOMAX INFORMATICS AG
BIO-RAD LABORATORIES INC.
BIOTECH SUPPORT GROUP
BIOTEK INSTRUMENTS INC.
BRUKER
CEPHEID
CHARLES RIVER LABORATORIES INTERNATIONAL INC.
CHENOMX
CISBIO BIOASSAYS
CODEX BIOSOLUTIONS INC.
COMPUGEN LTD.
EMD MILLIPORE
GE HEALTHCARE LIFESCIENCES
GENEVA BIOINFORMATICS SA
GENOMATIX SOFTWARE GMBH
GENOSPLICE TECHNOLOGY
HAMILTON ROBOTICS INC.
HIGHCHEM LTD. SLOVAKIA
HITACHI HIGH-TECHNOLOGIES CORP.
HUMAN METABOLOME TECHNOLOGIES INC.
ILLUMINA INC.
INTEGRATED DNA TECHNOLOGIES INC.
IROA TECHNOLOGIES (FORMERLY NEXTGEN METABOLOMICS)
JEOL LTD
LEICA MICROSYSTEMS
LONZA GROUP AG
METABOLON INC.
MOLECULAR DEVICES LLC
MULTISPAN INC.
OPGEN INC.
PERKINELMER INC.
PROMEGA CORP.
QIAGEN NV
ROCHE HOLDING LTD
SHIMADZU
SIDMAP LLC
SIGMA-ALDRICH CORP.
SOMALOGIC INC.
THERMO FISHER SCIENTIFIC INC.
THOMSON REUTERS
WATERS CORP.
ZEISS

Chapter- 12: APPENDIX-ABBREVIATIONS 4

List of Tables

Summary Table : GLOBAL REVENUE OF DRUG DISCOVERY TECHNOLOGIES, BY REGION, THROUGH 2019
Table 1 : CELL BIOLOGY REAGENTS AND THEIR FUNCTIONS
Table 2 : PROTEIN MICROARRAY AND THEIR FUNCTIONS
Table 3 : DIFFERENCE BETWEEN SOLID-PHASE AND SOLUTION-PHASE SYNTHESIS
Table 4 : NEW DEVELOPMENTS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2014
Table 5 : AWARDS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2014
Table 6 : NEW DEVELOPMENTS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2013
Table 7 : AWARDS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2013
Table 8 : NEW DEVELOPMENTS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2012
Table 9 : AWARDS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2012
Table 10 : GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY TYPE, THROUGH 2019
Table 11 : GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, THROUGH 2019
Table 12 : GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS AND TECHNOLOGY, BY TYPE, THROUGH 2019
Table 13 : GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS BY TYPE, THROUGH 2019
Table 14 : GLOBAL REVENUE FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGY BY TYPE, THROUGH 2019
Table 15 : GLOBAL REVENUE FOR GENOMIC DRUG DISCOVERY TECHNOLOGY BY TYPE, THROUGH 2019
Table 16 : GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY, THROUGH 2019
Table 17 : GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY TYPE, THROUGH 2019
Table 18 : MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES AND INSTRUMENTATIONS BY TYPE, 2013
Table 19 : GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY REGION, THROUGH 2019
Table 20 : GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY BY REGION, THROUGH 2019
Table 21 : GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS FOR DRUG DISCOVERY BY REGION, THROUGH 2019
Table 22 : GLOBAL REVENUE FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY BY REGION, THROUGH 2019
Table 23 : GLOBAL REVENUE FOR MASS SPECTROMETRY EQUIPMENT AND ACCESSORIES BY REGION, THROUGH 2019
Table 24 : GLOBAL REVENUE FOR NUCLEAR MAGNETIC RESONANCE EQUIPMENT AND ACCESSORIES BY REGION, THROUGH 2019
Table 25 : GLOBAL REVENUE FOR MICROSCOPY EQUIPMENT AND ACCESSORIES BY REGION, THROUGH 2019
Table 26 : GLOBAL REVENUE FOR X-RAY CRYSTALLOGRAPHY EQUIPMENT AND ACCESSORIES BY REGION, THROUGH 2019
Table 27 : GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS FOR DRUG DISCOVERY BY REGION, THROUGH 2019
Table 28 : GLOBAL REVENUE FOR CELL BASED ASSAYS FOR DRUG DISCOVERY BY REGION, THROUGH 2019
Table 29 : GLOBAL REVENUE FOR CELL BIOLOGY REAGENTS BY REGION, THROUGH 2019
Table 30 : GLOBAL REVENUE FOR PROTEOMICS TECHNOLOGY FOR DRUG DISCOVERY BY REGION, THROUGH 2019
Table 31 : GLOBAL REVENUE FOR TWO-DIMENSIONAL GEL ELECTROPHORESIS BY REGION, THROUGH 2019
Table 32 : GLOBAL REVENUE FOR PROTEIN CHIP TECHNOLOGY BY REGION, THROUGH 2019
Table 33 : GLOBAL REVENUE FOR GENOMICS TECHNOLOGY FOR DRUG DISCOVERY, BY REGION, THROUGH 2019
Table 34 : GLOBAL REVENUE FOR POLYMERASE CHAIN REACTION BY REGION, THROUGH 2019
Table 35 : GLOBAL REVENUE FOR DEOXYRIBONUCLEIC ACID MICROARRAYS BY REGION, THROUGH 2019
Table 36 : GLOBAL REVENUE FOR RIBONUCLEIC ACID INTERFERENCE TECHNOLOGY BY REGION, THROUGH 2019
Table 37 : GLOBAL REVENUE FOR NEXT-GENERATION SEQUENCING TECHNOLOGY BY REGION, THROUGH 2019
Table 38 : GLOBAL REVENUE FOR EPIGENETICS TECHNOLOGY BY REGION, THROUGH 2019
Table 39 : GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY FOR DRUG DISCOVERY BY REGION, THROUGH 2019
Table 40 : GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY REGION, THROUGH 2019
Table 41 : GLOBAL REVENUE FOR METABOLOMICS TECHNOLOGY BY REGION, THROUGH 2019
Table 42 : GLOBAL REVENUE FOR COMBINATORIAL CHEMISTRY BY REGION, THROUGH 2019
Table 43 : GLOBAL REVENUE FOR SYSTEMS BIOLOGY BY REGION, THROUGH 2019
Table 44 : GLOBAL REVENUE FOR NANOTECHNOLOGY BY REGION, THROUGH 2019
Table 45 : TABLE 45 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES BY REGION, 2013
Table 46 : LEADING MANUFACTURERS/SUPPLIERS OF HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2013
Table 47 : MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2013
Table 48 : LEADING MANUFACTURERS/SUPPLIERS OF BIOANALYTICAL INSTRUMENTS, 2013
Table 49 : MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR BIOANALYTICAL INSTRUMENTS, 2013
Table 50 : LEADING MANUFACTURERS/SUPPLIERS OF CELL-BASED ASSAYS AND REAGENTS, 2013
Table 51 : MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR CELL-BASED ASSAYS AND REAGENTS, 2013
Table 52 : LEADING MANUFACTURERS/SUPPLIERS OF PROTEOMICS TECHNOLOGY, 2013
Table 53 : MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR PROTEOMICS TECHNOLOGY, 2013
Table 54 : LEADING MANUFACTURERS/SUPPLIERS OF GENOMICS TECHNOLOGY, 2013
Table 55 : MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR GENOMICS TECHNOLOGY, 2013
Table 56 : LEADING MANUFACTURERS/SUPPLIERS OF BIOINFORMATICS TECHNOLOGY, 2013
Table 57 : MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR BIOINFORMATICS TECHNOLOGY, 2013
Table 58 : LEADING MANUFACTURERS/SUPPLIERS OF OTHER DRUG DISCOVERY TECHNOLOGIES, 2013
Table 59 : MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2013
Table 60 : GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, THROUGH 2019
Table 61 : MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, 2013
Table 62 : GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY BY APPLICATION, THROUGH 2019
Table 63 : GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS BY APPLICATION, THROUGH 2019
Table 64 : GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS BY APPLICATION, THROUGH 2019
Table 65 : GLOBAL REVENUE FOR PROTEOMICS TECHNOLOGY BY APPLICATION, THROUGH 2019
Table 66 : GLOBAL REVENUE FOR GENOMICS TECHNOLOGY BY APPLICATION, THROUGH 2019
Table 67 : GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY BY APPLICATION, THROUGH 2019
Table 68 : GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, THROUGH 2019
Table 69 : TOTAL NUMBER OF U.S. PATENTS BY YEAR, 2012 TO JULY 2014
Table 70 : NUMBER OF U.S. PATENTS BY DRUG DISCOVERY TECHNOLOGIES AND PRODUCTS CATEGORY, 2012 TO JULY 2014
Table 71 : NUMBER OF U.S. PATENTS BY COUNTRY FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014
Table 72 : PATENT SHARES BY COUNTRY FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014
Table 73 : NUMBER OF U.S. PATENTS BY COUNTRY FOR BIOANALYTICAL INSTRUMENTS, 2012 TO JULY 2014
Table 74 : PATENT SHARES BY COUNTRY FOR BIOANALYTICAL INSTRUMENTS, 2012 TO JULY 2014
Table 75 : NUMBER OF U.S. PATENTS BY COUNTRY FOR CELL-BASED ASSAYS AND REAGENTS, 2012 TO JULY 2014
Table 76 : PATENT SHARES BY COUNTRY FOR CELL-BASED ASSAYS AND REAGENTS, 2012 TO JULY 2014
Table 77 : NUMBER OF U.S. PATENTS BY COUNTRY FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014
Table 78 : PATENT SHARES BY COUNTRY FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014
Table 79 : NUMBER OF U.S. PATENTS BY COUNTRY FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014
Table 80 : PATENT SHARES BY COUNTRY FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014
Table 81 : NUMBER OF U.S. PATENTS BY COUNTRY FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014
Table 82 : PATENT SHARES BY COUNTRY FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014
Table 83 : NUMBER OF U.S. PATENTS BY COUNTRY FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014
Table 84 : PATENT SHARES BY COUNTRY FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014
Table 85 : NUMBER OF U.S. PATENTS BY COMPANY FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014
Table 86 : NUMBER OF U.S. PATENTS BY COMPANY FOR BIOANALYTICAL INSTRUMENTS, 2012 TO JULY 2014
Table 87 : NUMBER OF U.S. PATENTS BY COMPANY FOR CELL-BASED ASSAYS AND REAGENTS, 2012 TO JULY 2014
Table 88 : NUMBER OF U.S. PATENTS BY COMPANY FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014
Table 89 : NUMBER OF U.S. PATENTS BY COMPANY FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014
Table 90 : NUMBER OF U.S. PATENTS BY COMPANY FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014
Table 91 : NUMBER OF U.S. PATENTS BY COMPANY FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014
Table 92 : U.S. PATENTS BY ASSIGNEE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014
Table 93 : U.S. PATENTS BY ASSIGNEE FOR BIOANALYTICAL INSTRUMENTS, 2012 TO JULY 2014
Table 94 : U.S. PATENTS BY ASSIGNEE FOR CELL-BASED ASSAYS AND REAGENTS, 2012 TO JULY 2014
Table 95 : U.S. PATENTS BY ASSIGNEE FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014
Table 96 : U.S. PATENTS BY ASSIGNEE FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014
Table 97 : U.S. PATENTS BY ASSIGNEE FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014
Table 98 : U.S. PATENTS BY ASSIGNEE FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014

List of Figures

Summary Figure : GLOBAL REVENUE OF DRUG DISCOVERY TECHNOLOGIES, BY REGION, 2012-2019
Figure 1 : DRUG DISCOVERY PROCESS
Figure 2 : STEPS TO DRUG DISCOVERY UNTIL REGULATORY APPROVAL
Figure 3 : GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY TYPE, 2012-2019
Figure 4 : GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012-2019
Figure 5 : GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS AND TECHNOLOGY, BY TYPE, 2012-2019
Figure 6 : GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS BY TYPE, 2012-2019
Figure 7 : GLOBAL REVENUE FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGY BY TYPE, 2012-2019
Figure 8 : GLOBAL REVENUE FOR GENOMIC DRUG DISCOVERY TECHNOLOGY BY TYPE, 2012-2019
Figure 9 : GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY, 2012-2019
Figure 10 : GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY TYPE, 2012-2019
Figure 11 : MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES AND INSTRUMENTATIONS BY TYPE, 2013
Figure 12 : GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY REGION, 2012-2019
Figure 13 : GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY BY REGION, 2012-2019
Figure 14 : GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS FOR DRUG DISCOVERY BY REGION, 2012-2019
Figure 15 : GLOBAL REVENUE FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY BY REGION, 2012-2019
Figure 16 : GLOBAL REVENUE FOR MASS SPECTROMETRY EQUIPMENT AND ACCESSORIES BY REGION, 2012-2019
Figure 17 : GLOBAL REVENUE FOR NUCLEAR MAGNETIC RESONANCE EQUIPMENT AND ACCESSORIES BY REGION, 2012-2019
Figure 18 : GLOBAL REVENUE FOR MICROSCOPY EQUIPMENT AND ACCESSORIES BY REGION, 2012-2019
Figure 19 : GLOBAL REVENUE FOR X-RAY CRYSTALLOGRAPHY EQUIPMENT AND ACCESSORIES BY REGION, 2012-2019
Figure 20 : GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS FOR DRUG DISCOVERY BY REGION, 2012-2019
Figure 21 : GLOBAL REVENUE FOR CELL BASED ASSAYS FOR DRUG DISCOVERY BY REGION, 2012-2019
Figure 22 : GLOBAL REVENUE FOR CELL BIOLOGY REAGENTS BY REGION, 2012-2019
Figure 23 : GLOBAL REVENUE FOR PROTEOMICS TECHNOLOGY FOR DRUG DISCOVERY BY REGION, 2012-2019
Figure 24 : GLOBAL REVENUE FOR TWO-DIMENSIONAL GEL ELECTROPHORESIS BY REGION, 2012-2019
Figure 25 : GLOBAL REVENUE FOR PROTEIN CHIP TECHNOLOGY BY REGION, 2012-2019
Figure 26 : GLOBAL REVENUE FOR GENOMICS TECHNOLOGY FOR DRUG DISCOVERY, BY REGION, 2012-2019
Figure 27 : GLOBAL REVENUE FOR POLYMERASE CHAIN REACTION BY REGION, 2012-2019
Figure 28 : GLOBAL REVENUE FOR DEOXYRIBONUCLEIC ACID MICROARRAYS BY REGION, 2012-2019
Figure 29 : GLOBAL REVENUE FOR RIBONUCLEIC ACID INTERFERENCE TECHNOLOGY BY REGION, 2012-2019
Figure 30 : GLOBAL REVENUE FOR NEXT-GENERATION SEQUENCING TECHNOLOGY BY REGION, 2012-2019
Figure 31 : GLOBAL REVENUE FOR EPIGENETICS TECHNOLOGY BY REGION, 2012- 2019
Figure 32 : GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY FOR DRUG DISCOVERY BY REGION, 2012-2019
Figure 33 : GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY REGION, 2012-2019
Figure 34 : GLOBAL REVENUE FOR METABOLOMICS TECHNOLOGY BY REGION, 2012-2019
Figure 35 : GLOBAL REVENUE FOR COMBINATORIAL CHEMISTRY BY REGION, 2012-2019
Figure 36 : GLOBAL REVENUE FOR SYSTEMS BIOLOGY BY REGION, 2012-2019
Figure 37 : GLOBAL REVENUE FOR NANOTECHNOLOGY BY REGION, 2012-2019
Figure 38 : MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES BY REGION, 2013
Figure 39 : MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2013
Figure 40 : MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR BIOANALYTICAL INSTRUMENTS, 2013
Figure 41 : MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR CELL-BASED ASSAYS AND REAGENTS, 2013
Figure 42 : MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR PROTEOMICS TECHNOLOGY, 2013
Figure 43 : MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR GENOMICS TECHNOLOGY, 2013
Figure 44 : MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR BIOINFORMATICS TECHNOLOGY, 2013
Figure 45 : MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2013
Figure 46 : GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, 2012-2019
Figure 47 : MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, 2013
Figure 48 : GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY BY APPLICATION, 2012-2019
Figure 49 : GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS BY APPLICATION, 2012-2019
Figure 50 : GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS BY APPLICATION, 2012-2019
Figure 51 : GLOBAL REVENUE FOR PROTEOMICS TECHNOLOGY BY APPLICATION, 2012-2019
Figure 52 : GLOBAL REVENUE FOR GENOMICS TECHNOLOGY BY APPLICATION, 2012-2019
Figure 53 : GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY BY APPLICATION, 2012-2019
Figure 54 : GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, 2012-2019
Figure 55 : TOTAL NUMBER OF U.S. PATENTS BY YEAR, 2012 TO JULY 2014
Figure 56 : PATENT SHARES BY COUNTRY FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014
Figure 57 : PATENT SHARES BY COUNTRY FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014
Figure 58 : PATENT SHARES BY COUNTRY FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014
Figure 59 : PATENT SHARES BY COUNTRY FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012-2014 (JULY)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Proteomics Market: By Technology (Chromatography, Mass Spectroscopy, Others), By Product Type (Instruments, Reagents, Others), By Services (Laboratory, Data Analysis), By End-User (Drug discovery, Clinical Diagnosis, and Others) & By Region-Forecast (2016

Proteomics Market: By Technology (Chromatography, Mass Spectroscopy, Others), By Product Type (Instruments, Reagents, Others), By Services (Laboratory, Data Analysis), By End-User (Drug discovery, Clinical Diagnosis, and Others) & By Region-Forecast (2016

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Proteomic is a systematic study of proteome on a broader way to collect information on protein abundances, their variations and modifications, along with their interacting partners and networks, in orde ...

Drug Discovery Technologies - Global Market Outlook (2016-2022)

Drug Discovery Technologies - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Drug Discovery Technologies market is estimated at $XX million in 2015 and is expected to reach $XX million by 2022 growing at a CAGR of XX% from 2015 to 2022. ...

Global Lab Automation in Drug Discovery Market Segmented by Type of Equipment, Software, Analyzers, Plate Readers and Geography Forecasts, Shares and Trends (2016 - 2021)

Global Lab Automation in Drug Discovery Market Segmented by Type of Equipment, Software, Analyzers, Plate Readers and Geography Forecasts, Shares and Trends (2016 - 2021)

  • $ 4250
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The emergence of robotics has transformed the typical workday for scientists around the world. With the advent of automation techniques, scientists are now able to set up, run, and analyze the results ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.